XML 21 R11.htm IDEA: XBRL DOCUMENT v3.21.1
Marketable Securities
3 Months Ended
Mar. 31, 2021
Investments Debt And Equity Securities [Abstract]  
Marketable Securities

4.

Marketable Securities

As of March 31, 2021, and December 31, 2020, the fair value of available-for-sale marketable securities by type of security was as follows:

 

 

March 31, 2021

 

(In thousands)

 

Amortized Cost

 

 

Gross Unrealized

Gains

 

 

Gross Unrealized

Losses

 

 

Fair Value

 

Commercial paper

 

$

8,893

 

 

$

 

 

$

 

 

$

8,893

 

Corporate bonds

 

 

46,690

 

 

 

1

 

 

 

(11

)

 

$

46,680

 

 

 

$

55,583

 

 

$

1

 

 

$

(11

)

 

$

55,573

 

 

 

 

December 31, 2020

 

(In thousands)

 

Amortized Cost

 

 

Gross Unrealized

Gains

 

 

Gross Unrealized

Losses

 

 

Fair Value

 

Commercial paper

 

$

6,890

 

 

$

 

 

$

 

 

$

6,890

 

U.S. government obligations

 

 

9,997

 

 

 

1

 

 

 

 

 

 

9,998

 

Corporate bonds

 

 

50,700

 

 

 

2

 

 

 

(14

)

 

 

50,688

 

 

 

$

67,587

 

 

$

3

 

 

$

(14

)

 

$

67,576

 

As of March 31, 2021, and December 31, 2020, marketable securities consisted of $55.6 million and $67.6 million, respectively, of investments that mature within 12 months. There were no investments with maturities greater than 12 months as of March 31, 2021, and December 31, 2020. The Company assesses its available-for-sale marketable securities for impairment on a quarterly basis in accordance with ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. There were no material impairments of the Company’s available-for-sale marketable securities measured and carried at fair value during the three months ended March 31, 2021.